Where does Altor Bioscience LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Altor Bioscience LLC ranks #6,619 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Altor Bioscience LLC hold?

Altor Bioscience LLC holds 50 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Altor Bioscience LLC's Innovation Score?

Altor Bioscience LLC has an Innovation Score of 41.4 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Altor Bioscience LLC focus on?

Altor Bioscience LLC's top technology area is C07K (Peptides) with 49 patents, ranking #183 of 3,615 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Altor Bioscience LLC's patent grant rate increasing or decreasing?

Altor Bioscience LLC's recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Altor Bioscience LLC's patents?

Altor Bioscience LLC's patents average 12.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Altor Bioscience LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Altor Bioscience LLC

USPTO PatentsView assignee record - 50 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Altor ranks #6,619 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 9 technology areas.

#6,619
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.4/100): 12.4
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6619 · US Corporation #6,619 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 50 grants
UPPER-Q #6,619/49,997
PHOTO-FINISH Ablative Solutions
CPC-NARROW C07K · 9 areas
INNOV-PAR 41.4/100
CLAIMS-RICH 12.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ablative Solutions, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Altor’s 41.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.6 pts (33%) Velocity 9.7 pts (23%) Breadth 10.6 pts (26%) Claim depth 7.4 pts (18%)

Qualcomm Incorporated · highest

85
Altor Bioscience · this assignee

41
Armament Systems… · near

41
Continental… · near

41
Kolmar Korea · near

41
Yoke Industrial · near

41
3D Lighting… · lowest

7

What this shows Altor's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Altor?

Each dot is one of Altor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Altor’s own 12.4 claims/patent is at or below the 20.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Altor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Altor's grants concentrate

Altor Bioscience LLC is a focused PatentsView assignee: 9 CPC subclasses with 98% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (8 grants) versus a trough of 2 in 2015. By volume, Altor sits between Ablative Solutions, Inc. and Bradford Company.

Altor's three-year grant acceleration

Altor Bioscience LLC shows 19 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ablative Solutions

50
Abraxis Bioscience

50
Akzenta Paneele +…

50
Alentic Microscie…

50
Beijing Youzhuju…

50
Barrette Outdoor…

50
Beigene

50
Bradford

50
Altor Bioscience ◀

50

What this shows Altor holds 50 patents at rank #6,623, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Altor

By rank, the assignees closest to #6,623 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Altor's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Altor, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Altor ranks #183 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Yoke Industrial Corp. 41 Armament Systems and Procedures, Inc. 41 Kolmar Korea Co., Ltd. 41 Continental Advanced Lidar Solutions US, Inc. 41

Similar claim depth

Nearest assignees by average claims per patent (12.4 here).

Univation Technologies, LLC 12.4 avg Central Glass Company, Limited 12.4 avg Autolus Limited 12.3 avg Gerresheimer Regensburg GmbH 12.4 avg

Altor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Altor Bioscience LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	4.0%
2016	4	8.0%
2017	2	4.0%
2018	2	4.0%
2019	2	4.0%
2020	3	6.0%
2021	8	16.0%
2022	6	12.0%
2023	5	10.0%
2024	8	16.0%
2025partial year	8	16.0%

Which technologies does Altor Bioscience LLC patent most?

C07K - Peptides 49

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 48

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 45

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 28

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 18

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 13

C12Y - Enzymes 3

A21D - Treatment OF Flour OR Dough FOR Baking, e.g. BY Addition OF MATERIALS; BAKING; Bakery Products 3

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Altor Bioscience LLC's patent record in context - here's where to go next.

Altor Bioscience LLC's lead technology class is C07K (Peptides), 98% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #6,619 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Altor Bioscience LLC against Ablative Solutions, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.